等待開盤 09-24 09:30:00 美东时间
-1.180
-7.95%
三巫日波动警告!美股今夜迎流动性考验;Strategy盘前再升3%,小摩坚定看涨比特币潜力超黄金;巴菲特“谢幕”!官宣卸任伯克希尔董事长>>
09-18 20:33
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 150 points on Friday. Shares of Xenon Pharmaceuticals Inc (NASDAQ:XENE) fell sharply in pre-market trading after the company announced a temporary pause in enrollment for new patients in its ongoing psychiatry st...
09-18 20:01
AI多头集体出手!英特尔、AMD、美光Call单飙涨逾400%;CoreWeave融资再加码,期权成交环比激增逾2倍>>
09-18 17:57
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-14 18:20
Biohaven shares gave up nearly 15% in a single session on September 10, 2026 following the FDA's partial clinical hold on new-patient enrollment in the BHV-7000/opakalim epilepsy trials NEW ...
09-12 06:28
今日重点评级关注:康托·菲茨杰拉德:维持SOL Strategies"超配"评级,目标价从2.8美元升至6.2美元;康托·菲茨杰拉德:维持Sui Group Holdings"超配"评级,目标价从1.7美元升至3.4美元
09-11 14:30
Biohaven Ltd. (NYSE:BHVN) on Thursday announced a partial clinical hold issued by the U.S. Food and Drug Administration (FDA) on new patient enrollment for its BHV-7000 program, while maintaining timelines for its lead pivotal study in refractory focal epilepsy. FDA Issued Partial Hold On New Enroll...
09-10 22:43
今日重点评级关注:Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.3美元升至8.45美元;摩根大通:维持Vera Therapeutics"超配"评级,目标价从76美元升至83美元
09-09 15:36
Biohaven (BHVN) shares slipped on Tuesday after RBC Capital Markets downgraded the company to Sector Perform from Outperform, arguing that its recent licensing deal with South Korea's SK Biopharmaceut...
09-09 00:28
RBC Capital analyst Leonid Timashev downgrades Biohaven (NYSE:BHVN) from Outperform to Sector Perform and lowers the price target from $23 to $19.
09-08 22:35